Subject(s)

COVID-19/complications , Factor XIII Deficiency/complications , Factor XIII Deficiency/virology , Hemorrhage/complications , Hemorrhage/virology , COVID-19/blood , Female , Hemorrhage/pathology , Humans , Middle Aged , SARS-CoV-2/isolation & purification

Subject(s)

Betacoronavirus , Coronavirus Infections , Hemophilia A/therapy , Pandemics , Pneumonia, Viral , Antibodies, Bispecific/administration & dosage , Antibodies, Bispecific/therapeutic use , Antibodies, Monoclonal, Humanized/administration & dosage , Antibodies, Monoclonal, Humanized/therapeutic use , COVID-19 , Coronavirus Infections/prevention & control , Drug Substitution , Hemophilia A/complications , Hemorrhage/etiology , Hemorrhage/prevention & control , Hemorrhage/therapy , Humans , Injections, Subcutaneous , Office Visits , Pandemics/prevention & control , Patient Acceptance of Health Care , Patient Education as Topic , Pneumonia, Viral/prevention & control , SARS-CoV-2

Subject(s)

Betacoronavirus , Coronavirus Infections/epidemiology , Hemophilia A/therapy , Hemophilia B/therapy , Pandemics , Pneumonia, Viral/epidemiology , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Antibodies, Bispecific/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , COVID-19 , Clinical Trials as Topic , Comorbidity , Continuity of Patient Care , Contraindications, Drug , Coronavirus Infections/blood , Coronavirus Infections/complications , Coronavirus Infections/prevention & control , Delivery of Health Care , Disease Management , Drug Substitution , Factor IX/supply & distribution , Factor IX/therapeutic use , Factor VIII/supply & distribution , Factor VIII/therapeutic use , Fibrinolytic Agents/adverse effects , Fibrinolytic Agents/therapeutic use , Genetic Therapy , Health Resources/supply & distribution , Hemophilia A/complications , Hemophilia A/epidemiology , Hemophilia B/complications , Hemophilia B/epidemiology , Hemorrhage/etiology , Hemorrhage/prevention & control , Humans , Pandemics/prevention & control , Pneumonia, Viral/blood , Pneumonia, Viral/complications , Pneumonia, Viral/prevention & control , Professional-Patient Relations , SARS-CoV-2 , Social Media , Telemedicine , Thrombophilia/etiology